Identification of aberrantly expressed long non-coding RNAs in ovarian high-grade serous carcinoma cells

被引:2
|
作者
Nakashima, Kengo [1 ]
Sato, Shun [1 ]
Tamura, Isao [1 ]
Hayashi-Okada, Maki [1 ]
Tamehisa, Tetsuro [1 ]
Kajimura, Takuya [1 ]
Sueoka, Kotaro [1 ]
Sugino, Norihiro [1 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Dept Obstet & Gynecol, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan
关键词
long non-coding RNAs (lncRNAs); MEG3; ovarian cancer; ovarian high-grade serous carcinoma (HGSC);
D O I
10.1002/rmb2.12330
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose To identify the aberrantly expressed long non-coding RNAs (lncRNAs) in ovarian high-grade serous carcinoma (HGSC). Methods Total RNA was isolated in HGSC cell lines, ovarian surface epithelial cells, and normal ovaries. Aberrantly expressed lncRNAs in HGSC were identified by PCR array, which analyzes 84 kinds of lncRNAs. To infer their functions, HGSC cell lines with different levels of expression of the identified lncRNAs were established, and then, activities of proliferation, migration, and apoptosis were examined. Expression levels of the identified lncRNAs were also examined in multiple ovarian HGSC tissues. Results Ten aberrantly expressed lncRNAs, six upregulated and four downregulated, were identified in the HGSC cell lines. The authors established four HGSC cell lines: in two of the cell lines, one of the upregulated lncRNAs was knocked down, and in two other cell lines, one of the downregulated lncRNAs (MEG3 and POU5F1P5) was overexpressed. Migration activities were inhibited in the HGSC cell lines overexpressing MEG3 or POU5F1P5 while there were no differences in proliferation and apoptosis between the established and control cell lines. The four lncRNAs downregulated in the HGSC cell lines were also observed to be downregulated in ovarian HGSC tissues. Conclusion The authors identified four downregulated lncRNAs in ovarian HGSC.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [31] Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients
    Petersen, Patrick H. D.
    Lopacinska-Jorgensen, Joanna
    Hogdall, Claus K.
    Hogdall, Estrid V.
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (12) : 10235 - 10247
  • [32] Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients
    Patrick H.D. Petersen
    Joanna Lopacinska-Jørgensen
    Claus K. Høgdall
    Estrid V. Høgdall
    Molecular Biology Reports, 2023, 50 : 10235 - 10247
  • [33] Long non-coding RNAs in hepatocellular carcinoma
    Ge, Wen-jun
    Huang, Huan
    Wang, Tao
    Zeng, Wei-hong
    Guo, Min
    Ren, Chen-ran
    Fan, Ting-yu
    Liu, Fang
    Zeng, Xi
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [34] Long Non-Coding RNAs in Endometrial Carcinoma
    Smolle, Maria A.
    Bullock, Marc D.
    Ling, Hui
    Pichler, Martin
    Haybaeck, Johannes
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (11) : 26463 - 26472
  • [35] Identification and function of long non-coding RNAs
    Young, Robert S.
    Ponting, Chris P.
    ROLE OF NON-CODING RNAS IN BIOLOGY, 2013, 54 : 113 - 126
  • [36] Aberrantly Expressed Non-Coding RNAs in the Placenta and Their Role in the Pathophysiology of Gestational Diabetes Mellitus
    Du, Runyu
    Wu, Na
    Li, Ling
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 3719 - 3732
  • [37] Personalising Treatment for High-Grade Serous Ovarian Carcinoma
    Cojocaru, E.
    Parkinson, C. A.
    Brenton, J. D.
    CLINICAL ONCOLOGY, 2018, 30 (08) : 515 - 524
  • [38] Molecular Management of High-Grade Serous Ovarian Carcinoma
    Punzon-Jimenez, Paula
    Lago, Victor
    Domingo, Santiago
    Simon, Carlos
    Mas, Aymara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [39] An overview of long non-coding RNAs in ovarian cancers
    Meryet-Figuiere, Matthieu
    Lambert, Bernard
    Gauduchon, Pascal
    Vigneron, Nicolas
    Brotin, Emilie
    Poulain, Laurent
    Denoyelle, Christophe
    ONCOTARGET, 2016, 7 (28) : 44719 - 44734
  • [40] Clinical Outcomes of Patients with High-Grade Ovarian Carcinoma Arising in Endometriosis Compared to Ovarian High-Grade Serous Carcinoma
    Ibrahim Yalcin
    Hanifi Sahin
    Mustafa Erkan Sari
    Asuman Nihan Haberal
    Eda Adeviye Sahin
    Husnu Celik
    Mehmet Mutlu Meydanli
    Ali Ayhan
    Indian Journal of Gynecologic Oncology, 2021, 19